Tauben Averbuch
YOU?
Author Swipe
View article: Great debate: artificial intelligence will replace much of what cardiologists do
Great debate: artificial intelligence will replace much of what cardiologists do Open
Graphical Abstract The role of AI in cardiovascular care. Artificial intelligence offers powerful tools to assist in the care of cardiac patients, but it remains to be seen if cardiologists will be replaced. Artificial intelligence can ass…
View article: Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization
Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization Open
Aims Risk prediction indices used in worsening heart failure (HF) vary in complexity, performance, and the type of datasets in which they were validated. We compared the performance of seven risk prediction indices in a contemporary cohort…
View article: Long‐term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure
Long‐term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure Open
Aims Heart failure ( HF ) is a leading cause of hospitalization, and sex differences in care have been described. We assessed sex‐specific clinical outcomes and healthcare resource utilization following hospitalization for HF. Methods and …
View article: Effect of a transitional care model following hospitalization for heart failure: 3‐year outcomes of the Patient‐Centered Care Transitions in Heart Failure (PACT‐HF) randomized controlled trial
Effect of a transitional care model following hospitalization for heart failure: 3‐year outcomes of the Patient‐Centered Care Transitions in Heart Failure (PACT‐HF) randomized controlled trial Open
Aims Patients are at high risk of death or readmission following hospitalization for heart failure (HF). We tested the effect of a transitional care model that included month‐long nurse‐led home visits and long‐term heart function clinic v…
View article: Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries
Pharmaco‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries Open
Aims Heart failure with reduced ejection fraction (HFrEF) is treatable but guideline‐directed medical therapy (GDMT) may not be affordable or accessible to people living with the disease. Methods and results In this cross‐sectional survey,…
View article: Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies Open
Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by deficient activity of the enzyme alpha-galactosidase. While AFD is recognized as a progressive multi-system disorder, infiltrative cardiomyopathy causing a nu…
View article: Predicting Risk of Cardiotoxic Effects in Breast Cancer: Are We There Yet?
Predicting Risk of Cardiotoxic Effects in Breast Cancer: Are We There Yet? Open
Elisé G. Kaboré, MD; Conor Macdonald, PhD; Ahmed Kaboré, PhD; Romain Didier, MD; Patrick Arveux, MD, PhD; Nicolas Meda, MD, PhD; Marie-Christine Boutron-Ruault, MD, PhD; Charles Guenancia, MD, PhD
View article: Applications of artificial intelligence and machine learning in heart failure
Applications of artificial intelligence and machine learning in heart failure Open
Machine learning (ML) is a sub-field of artificial intelligence that uses computer algorithms to extract patterns from raw data, acquire knowledge without human input, and apply this knowledge for various tasks. Traditional statistical met…
View article: Urinary sodium: worth its salt?
Urinary sodium: worth its salt? Open
Persistent congestion during hospitalization for heart failure (HF) is associated with adverse outcomes.1 Loop diuretics treat congestion in HF, but the diuretic response varies between individuals and remains challenging to assess. Typica…
View article: Temporal trends in the inclusion of patient-reported outcomes in heart failure randomized trials published in high-impact medical journals: a systematic bibliometric review
Temporal trends in the inclusion of patient-reported outcomes in heart failure randomized trials published in high-impact medical journals: a systematic bibliometric review Open
Background Patient reported outcomes (PROs) are important measures of health, particularly in symptomatic conditions such as heart failure (HF), and regulatory agencies have encouraged their collection in randomized controlled trials (RCTs…
View article: Systematic review of academic bullying in medical settings: dynamics and consequences
Systematic review of academic bullying in medical settings: dynamics and consequences Open
Purpose To characterise the dynamics and consequences of bullying in academic medical settings, report factors that promote academic bullying and describe potential interventions. Design Systematic review. Data sources We searched EMBASE a…
View article: Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?
Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative? Open
Randomized clinical trials (RCTs) of heart failure with reduced ejection fraction (HFrEF) typically recruit patients at high risk of clinical outcomes during the follow-up period by including those with severe symptoms, comorbidities, elev…
View article: Derivation and validation of a two‐variable index to predict 30‐day outcomes following heart failure hospitalization
Derivation and validation of a two‐variable index to predict 30‐day outcomes following heart failure hospitalization Open
Background The LACE index—length of stay (L), acuity (A), Charlson co‐morbidities (C), and emergent visits (E)—predicts 30‐day outcomes following heart failure (HF) hospitalization but is complex to score. A simpler LE index (length of sta…
View article: The LENT index predicts 30 day outcomes following hospitalization for heart failure
The LENT index predicts 30 day outcomes following hospitalization for heart failure Open
Aims The LE index ( L ength of hospitalization plus number of E mergent visits ≤6 months) predicts 30 day all‐cause readmission or death following hospitalization for heart failure (HF). We combined N‐terminal pro‐B type natriuretic peptid…